MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 142 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $2,290,662 | +52.3% | 9,900 | -3.9% | 0.04% | +21.2% |
| Q3 2023 | $1,504,212 | -58.5% | 10,300 | -34.4% | 0.03% | -49.2% |
| Q2 2023 | $3,626,700 | +283.9% | 15,700 | +302.6% | 0.06% | +364.3% |
| Q1 2023 | $944,814 | -16.5% | 3,900 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $1,131,975 | -78.2% | 3,900 | -92.6% | 0.01% | -75.0% |
| Q1 2022 | $5,181,000 | +15.8% | 52,800 | 0.0% | 0.06% | +16.7% |
| Q4 2021 | $4,474,000 | +6.2% | 52,800 | 0.0% | 0.05% | +14.3% |
| Q3 2021 | $4,213,000 | +53.9% | 52,800 | +87.9% | 0.04% | +50.0% |
| Q2 2021 | $2,737,000 | – | 28,100 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paulson & Co. | 1,850,000 | $518,296,000 | 38.31% |
| Tao Capital Management LP | 130,529 | $36,569,005 | 29.98% |
| University of Wisconsin Foundation | 45,730 | $12,811,717 | 14.42% |
| AlpInvest Partners B.V. | 84,595 | $23,700,135 | 8.50% |
| RTW INVESTMENTS, LP | 1,915,862 | $536,747,898 | 8.31% |
| Propel Bio Management, LLC | 43,032 | $12,055,845 | 7.82% |
| Avoro Capital Advisors LLC | 2,055,555 | $575,884,289 | 7.67% |
| Baker Brothers Advisors | 1,974,590 | $553,201,134 | 7.07% |
| Tri Locum Partners LP | 65,352 | $18,309,016 | 4.63% |
| TCG Crossover Management, LLC | 149,283 | $41,823,125 | 4.36% |